A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy

Oncology Letters

Volumn 8, Issue 5, 2014, Pages 2000-2006

  Qin, Li ^a   Wang, Cheng Zheng ^a   Fan, Hui Jie ^b   Zhang, Chong Jian ^a   Zhang, Heng Wei ^a   Lv, Min Hao ^a   Cui, Shu De ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cyclic arginine glycine aspartic acid; Dual targeting; Glioma; Transferrin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; LIPOSOME; PACLITAXEL; TRANSFERRIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CANCER INHIBITION; CANCER THERAPY; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; DRUG UPTAKE; ENCAPSULATION; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR SPHEROID; ZETA POTENTIAL;

EID: 84907141177     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2449     Document Type: Article

References (32)

1. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG and Batchelor TT: Angiogenesis in brain tumours. Nat Rev Neurosci 8: 610-622, 2007.
2. Hegi ME, Diserens AC, Gorlia T, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003, 2005.
3. Ong BY, Ranganath SH, Lee LY, et al: Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials 30: 3189-3196, 2009.
4. Genc DB, Canpolat C and Berrak SG: Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. Support Care Cancer 20: 385-393, 2012.
5. Pang Z, Feng L, Hua R, et al: Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol Pharm 7: 1995-2005, 2010.
6. Pardridge WM: Brain drug development and brain drug targeting. Pharm Res 24: 1729-1732, 2007.
7. Guerin C, Olivi A, Weingart JD, Lawson HC and Brem H: Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs 22: 27-37, 2004.
8. Muthu MS and Feng SS: Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. Expert Opin Drug Deliv 10: 151-155, 2013.
9. Chaudhury A, Das S, Bunte RM and Chiu GN: Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft. Int J Nanomedicine 7: 739-751, 2012.
10. Rodriguez BL, Li X, Kiguchi K, DiGiovanni J, Unger EC and Cui Z: Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA. Nanomedicine (Lond) 7: 475-491, 2012.
11. Tzeng SY and Green JJ: Therapeutic nanomedicine for brain cancer. Ther Deliv 4: 687-704, 2013.
12. Marelli UK, Rechenmacher F, Sobahi TR, Mas-Moruno C and Kessler H: Tumor targeting via integrin ligands. Front Oncol 3: 222, 2013.
13. Li Q and Xu W: Novel anticancer targets and drug discovery in post genomic age. Curr Med Chem Anticancer Agents 5: 53-63, 2005.
14. Bidros DS and Vogelbaum MA: Novel drug delivery strategies in neuro-oncology. Neurotherapeutics 6: 539-546, 2009.
15. Gao JQ, Lv Q, Li LM, et al: Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials 34: 5628-5639, 2013.
16. Miyata S, Kawabata S, Hiramatsu R, et al: Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. Neurosurgery 68: 1380-1387, 2011.
17. Ying X, Wen H, Lu WL, et al: Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 141: 183-192, 2010.
18. Kurohane K, Namba Y and Oku N: Liposomes modified with a synthetic Arg-Gly-Asp mimetic inhibit lung metastasis of B16BL6 melanoma cells. Life Sci 68: 273-281, 2000.
19. Maeda T and Fujimoto K: A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating. Colloids Surf B Biointerfaces 49: 15-21, 2006.
20. Yang XJ, Koh CG, Liu SJ, et al: Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. Mol Pharm 6: 221-230, 2009.
21. Chiu SJ, Liu S, Perrotti D, Marcucci G and Lee RJ: Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release 112: 199-207, 2006.
22. Adam JF, Joubert A, Biston MC et al: Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64: 603-611, 2006.
23. Gu YT, Zhang H and Xue YX: Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model. Brain Res 1162: 1-8, 2007.
24. Zhang P, Hu L, Yin Q, Feng L and Li Y: Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy. Mol Pharm 9: 1590-1598, 2012.
25. Gidwani M and Singh AV: Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges. Curr Pharm Biotechnol 14: 1201-1212, 2014.
26. Torchilin V: Antibody-modified liposomes for cancer chemotherapy. Expert Opin Drug Deliv 5: 1003-1025, 2008.
27. Gastaldi L, Battaglia L, Peira E, et al: Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art. Eur J Pharm Biopharm 87: 433-444, 2014.
28. Wohlfart S, Gelperina S and Kreuter J: Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release 161: 264-273, 2012.
29. Hu K, Li J, Shen Y, et al: Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release 134: 55-61, 2009.
30. Farnsworth RH, Lackmann M, Achen MG and Stacker SA: Vascular remodeling in cancer. Oncogene 33: 3496-3505, 2014.
31. Jiang X, Xin H, Gu J, et al: Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel. Biomaterials 34: 1739-1746, 2013.
32. Thoma CR, Zimmermann M, Agarkova I, Kelm JM and Krek W: 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69-70: 29-41, 2014.